top of page

Warner Biddle

CEO at Kyverna Therapeutics former interim CEO at Kite a Gilead Company

​

Share
  • LinkedIn
  • Youtube
  • X
  • Instagram
How we drive innovation
MEETINGS
MEMBERS
Speakers
Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Uwe Gottschalk

Uwe Gottschalk is Operating Partner at Keensight Capital - Former CSO of Lonza

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Jesse McCool

CSO of Bionova Scientific

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Thomas Potgieter

Senior Vice President, Cell Therapy Development and Operations

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Angela Vollstedt, PhD MBA

Director Global Cell & Gene Therapies Portfolio Management at Novartis

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Paolo Martini

Chief Research & Development Officer at ReAlta Life Sciences former CSO at Moderna

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Gwendolyn Binder PhD

President, Science and Technology at Cabaletta Bio

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Jens Vogel

SVP & Head of Global Biologics Operating Unit, Merck & Co

bottom of page